F.A. Dilmanian , J. Kalef-Ezra , M.J. Petersen , G. Bozios , J. Vosswinkel , F. Giron , B. Ren , R. Yakupov , G. Antonakopoulos
{"title":"Could X-ray microbeams inhibit angioplasty-induced restenosis in the rat carotid artery?","authors":"F.A. Dilmanian , J. Kalef-Ezra , M.J. Petersen , G. Bozios , J. Vosswinkel , F. Giron , B. Ren , R. Yakupov , G. Antonakopoulos","doi":"10.1016/S1522-1865(03)00180-X","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Parallel, thin (<100 μm) planes of synchrotron-generated X rays, have been shown to spare normal tissues and preferentially damage tumors in animal models. The aim of the present study was to assess the effect of such microbeams directed unidirectionally on angioplasted rat carotid arteries.</p></div><div><h3>Methods and materials</h3><p>Three groups of Sprague–Dawley rats were studied: (a) rats with normal, untreated arteries, (b) rats treated by balloon angioplasty, but not irradiated, and (c) rats treated with balloon angioplasty and exposed to single fraction, unidirectional, parallel, microbeams an hour after angioplasty. The microbeam array, 15 mm wide×7.6 mm high, consisting of 27-μm-wide beam slices, spaced 200 μm center-to-center laterally traversed the damaged artery. The in-depth in-beam dose was 150 Gy, the “valley” dose (dose midway between microbeams resulting mainly from X-ray scattering) was 4.5 Gy on average, and the “integrated” (averaged) dose was 26 Gy.</p></div><div><h3>Results</h3><p>Microbeam irradiation, as given in the present study, was tolerated, but was insufficient to significantly suppress the neointimal hyperplasia.</p></div><div><h3>Discussion</h3><p>The microbeam dose used is considered low. Dose escalation would be necessary to reach conclusive results regarding the X-ray microbeam efficacy to control restenosis.</p></div>","PeriodicalId":80261,"journal":{"name":"Cardiovascular radiation medicine","volume":"4 3","pages":"Pages 139-145"},"PeriodicalIF":0.0000,"publicationDate":"2003-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1522-1865(03)00180-X","citationCount":"22","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiovascular radiation medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S152218650300180X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 22
Abstract
Background
Parallel, thin (<100 μm) planes of synchrotron-generated X rays, have been shown to spare normal tissues and preferentially damage tumors in animal models. The aim of the present study was to assess the effect of such microbeams directed unidirectionally on angioplasted rat carotid arteries.
Methods and materials
Three groups of Sprague–Dawley rats were studied: (a) rats with normal, untreated arteries, (b) rats treated by balloon angioplasty, but not irradiated, and (c) rats treated with balloon angioplasty and exposed to single fraction, unidirectional, parallel, microbeams an hour after angioplasty. The microbeam array, 15 mm wide×7.6 mm high, consisting of 27-μm-wide beam slices, spaced 200 μm center-to-center laterally traversed the damaged artery. The in-depth in-beam dose was 150 Gy, the “valley” dose (dose midway between microbeams resulting mainly from X-ray scattering) was 4.5 Gy on average, and the “integrated” (averaged) dose was 26 Gy.
Results
Microbeam irradiation, as given in the present study, was tolerated, but was insufficient to significantly suppress the neointimal hyperplasia.
Discussion
The microbeam dose used is considered low. Dose escalation would be necessary to reach conclusive results regarding the X-ray microbeam efficacy to control restenosis.